Key Highlights

  • Jupiter Neurosciences shares closed down 15% at $3.54.
  • Nasdaq issued a delisting notice for failure to meet the $35 million Market Value of listed securities requirement by the August 25 deadline.
  • The company plans to appeal the delisting notice.
  • Jupiter separately regained compliance with the $1 minimum bid price rule.

Jupiter Neurosciences, Inc. (NASDAQ: JUNS) shares closed down 15% at $3.54 after Nasdaq issued a delisting notice for failure to meet the $35 million market value of listed securities requirement by the August 25 deadline.

What Happened

The company plans to appeal the delisting notice, though it separately regained compliance with the $1 minimum bid price rule, a distinct listing requirement unrelated to the market value deficiency.

Market Reaction

Shares fell as investors weighed the delisting notice, which can affect Liquidity and institutional ownership even as the company pursues an appeal.

Outlook

The outcome of Jupiter Neurosciences' planned appeal represents the next major disclosed milestone for its continued Nasdaq listing status.